Consumer Group Urges Ban of Celebrex
Posted on: Tuesday, 25 January 2005, 09:00 CST
WASHINGTON - A consumer group urged the Food and Drug Administration on Monday to order the pain killers Celebrex and Bextra off the market.
Public Citizen charged that the two drugs from Pfizer Inc. increase the likelihood of heart attack.
Celebrex and Bextra are part of the family of drugs known as COX-2 inhibitors. Another drug in that group, Vioxx, was withdrawn last fall by its manufacturer, Merck & Co., because of heart problems.
Similar concerns have been expressed about Celebrex and Bextra, but they remain on the market.
Neither the FDA nor Pfizer responded immediately to requests for comment on Public Citizen's petition.
COX-2 inhibitors have been widely popular for use as pain killers and anti-inflammatory drugs with fewer stomach and intestinal side effects than such products as aspirin.
Pfizer shares fell 22 cents to close at $24.26 in Monday trading on the New York Stock Exchange, up from a 52-week low of just under $22 in December.
---
On the Net:
Public Citizen: http://www.publiccitizen.org
Food and Drug Administration: http://www.fda.gov
Source: Associated Press/AP Online
Related Articles
- Not All Drug Deaths Involve Illegal Drugs
- GSK's Offer Still Stands: Drug Maker Maintains Its Drug Giveaways for Low-Income Patients
- Counselors Decode New Drug Plan: Senior Citizens Get Explanations As Deadline Nears
- Pfizer Seeking Cancer Drug Approval ; FDA Filing Marks Attempt to Lead in Oncology
- Pfizer's Celebrex arthritis drug to add warnings
- Pfizer's Celebrex Drug to Add Warning
- Pfizer's Celebrex arthritis drug to add warning
- Pfizer's Celebrex May Cause Heart Problems, Drug Maker Says
- Five Drugs Panned by FDA Drug Reviewer
- Public Called 'Defenseless' Against Bad Drugs
 |
 |
User Comments (0)
RSS Feeds